Neogen Corporation $NEOG Shares Acquired by Healthcare of Ontario Pension Plan Trust Fund

Healthcare of Ontario Pension Plan Trust Fund increased its stake in Neogen Corporation (NASDAQ:NEOG) by 250.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,490,800 shares of the company’s stock after purchasing an additional 2,493,900 shares during the quarter. Healthcare of Ontario Pension Plan Trust Fund’s holdings in Neogen were worth $24,401,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of NEOG. UMB Bank n.a. lifted its holdings in Neogen by 238.2% in the fourth quarter. UMB Bank n.a. now owns 6,422 shares of the company’s stock worth $45,000 after purchasing an additional 4,523 shares during the period. Hantz Financial Services Inc. lifted its holdings in Neogen by 816.9% in the fourth quarter. Hantz Financial Services Inc. now owns 7,592 shares of the company’s stock worth $53,000 after purchasing an additional 6,764 shares during the period. Cresset Asset Management LLC acquired a new stake in Neogen in the second quarter worth about $53,000. Evergreen Capital Management LLC acquired a new stake in Neogen in the second quarter worth about $56,000. Finally, Northwestern Mutual Wealth Management Co. lifted its holdings in Neogen by 3,158.4% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 8,309 shares of the company’s stock worth $58,000 after purchasing an additional 8,054 shares during the period. Institutional investors and hedge funds own 96.73% of the company’s stock.

Analyst Ratings Changes

Several research firms recently weighed in on NEOG. William Blair reaffirmed a “market perform” rating on shares of Neogen in a report on Monday, March 2nd. Weiss Ratings reiterated a “sell (d-)” rating on shares of Neogen in a research report on Friday, April 10th. Finally, Wall Street Zen upgraded shares of Neogen from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. Two research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $10.67.

Neogen Price Performance

NASDAQ NEOG opened at $9.30 on Tuesday. The stock’s 50-day moving average price is $9.17 and its two-hundred day moving average price is $9.00. The company has a current ratio of 3.92, a quick ratio of 2.84 and a debt-to-equity ratio of 0.38. The company has a market cap of $2.02 billion, a PE ratio of -3.32, a PEG ratio of 4.07 and a beta of 1.81. Neogen Corporation has a 1 year low of $4.56 and a 1 year high of $11.43.

Neogen (NASDAQ:NEOG) last posted its quarterly earnings data on Thursday, April 9th. The company reported $0.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.05. The firm had revenue of $211.20 million for the quarter, compared to the consensus estimate of $204.62 million. Neogen had a positive return on equity of 2.35% and a negative net margin of 69.93%.The company’s revenue was down 4.4% on a year-over-year basis. On average, analysts predict that Neogen Corporation will post 0.23 EPS for the current year.

About Neogen

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user?friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.